Pharma Regulatory Services

New Drug Approvals

Accelerating Regulatory Approvals with Strategic Expertise. Bringing a new drug to the Indian market requires navigating a complex regulatory framework governed by the Central Drugs Standard Control Organization (CDSCO). From determining the applicable regulatory pathway to preparing comprehensive dossiers and coordinating with regulatory authorities, every stage demands technical expertise and meticulous planning.

20+ Years Regulatory Experience
CDSCO New Drug Experts
100% Success Rate
PAN India Support

Our Services Include

At Vaayath, we provide end-to-end regulatory consulting for new drug approvals, helping pharmaceutical companies achieve timely market authorization while ensuring compliance with the Drugs and Cosmetics Act, New Drugs and Clinical Trials Rules, 2019, and applicable CDSCO guidelines. Whether you are introducing an innovative product, a fixed-dose combination, a new indication, a modified dosage form or a biological product, our regulatory experts support you throughout the approval journey.

  • Regulatory pathway assessment and product classification
  • Gap analysis of available technical and regulatory data
  • Preparation and review of Common Technical Document (CTD/eCTD) dossiers
  • Preparation of application forms and regulatory documentation
  • Scientific and regulatory justification for new drug applications
  • Preparation of responses to CDSCO deficiency letters and technical queries
  • Coordination and liaison with CDSCO during the review process
  • Guidance on Subject Expert Committee (SEC) presentations and requirements
  • Post-approval regulatory support, including variations and lifecycle management

Our Approach

Every project follows a structured methodology to ensure efficiency and regulatory compliance.

01

Regulatory Assessment

Evaluate the product, applicable regulations and approval pathway.

02

Regulatory Strategy

Develop a tailored regulatory roadmap based on product characteristics and business objectives.

03

Documentation & Dossier Preparation

Prepare technically sound dossiers and supporting documentation in accordance with CDSCO requirements.

04

Submission & Authority Coordination

Manage regulatory submissions, authority interactions and timely responses to queries.

05

Approval & Lifecycle Support

Provide continued support for post-approval variations, renewals and ongoing regulatory compliance.

Who this is for

Indian manufacturersOverseas manufacturersImporters & marketers

Products We Support

Our expertise covers a wide range of products, including:

New Chemical Entities (NCEs)
Fixed Dose Combinations (FDCs)
Modified Release Formulations
Biological Products
Biosimilars
Vaccines
Novel Drug Delivery Systems
New Indications
Additional Strengths
Additional Dosage Forms
Orphan Drugs

Why This Service Matters

An effective regulatory strategy can significantly reduce approval timelines, minimize regulatory deficiencies and improve the likelihood of successful market authorization. Our team works proactively to identify potential regulatory challenges, develop practical solutions and facilitate smooth interactions with regulatory authorities.

Why Choose Vaayath?

  • 20+ years of regulatory expertise
  • Extensive experience with CDSCO regulatory procedures
  • Comprehensive technical dossier preparation and review
  • Dedicated regulatory consultants for every project
  • Practical and commercially focused regulatory strategies
  • End-to-end support from concept to commercialization

Frequently asked questions

Let's Talk

Ready to Obtain Your New Drug Approval?

Whether you are introducing an innovative therapy, a fixed-dose combination or a new formulation, Vaayath provides the strategic regulatory expertise needed to navigate the approval process efficiently and confidently. Speak to our regulatory experts today to discuss your project and develop the right approval strategy.